presence of crystals in a mannitol injection indicates that the product? a. has settled during transportation b. was formulated using sterile saline c. contains impurities and should be discarded d. was exposed to excessive cold

14. Denny has been diagnosed with cerebral edema. The healthcare provider says that a diuretic will be used to lower his ICP. The nurse anticipates that which diuretic will be prescribed, and why?   15. Mannitol IV has been prescribed.a. When the IV solution of mannitol arrives from the pharmacy, the nurse notes crystals in the fluid. What is the most appropriate action by the nurse?  b. What are potential complications the nurse should assess for when administering Mannitol?  c. What assessment findings would indicate the mannitol was effective?  16. Denny's mother is very distraught regarding his condition. She entered the room, turned on the lights, lowered the head of the bed and began shaking him to tell him "wake up!" What are your concerns?  17. Epidural bleeds are located between the                             and the                            , usually as a result of a linear fracture crossing the                             artery, and because these bleeds usually involve an artery, the bleeding tends to be                            , Subdural bleeds occur between the                             and the                            , usually affecting the veins that drain into the                           .

Which of the following is not a requirement for the packaging of sterile injectable products? A. Single dose products must be packaged in vials or ampules that contain less than 30 ml. B. A single dose container must be hermetic but once it has been opened it cannot be resealed with assurance that sterility has been maintained. C. A multi-dose container must be hermetic, but due to the packaging, the sterility of the contents is maintained to allow withdrawal of successive doses. D. The material of the container and its closure must not interact with the drug preparation in a way that alters the strength or efficacy of the product.

Which of the following will show “tyndall effect”?a. Milk b. Starch solutionc. Copper sulphate solution d. Blood

Identify the effect of the different biopharmaceutic factors below to the DISSOLUTION of drugs.Choices: INCREASE, DECREASE or NO EFFECT (use uppercase letters)Large particle size of the drug Crystalline polymorphs Excessive use of suspending agents For drugs that have very poor aqueous solubility Extended- or controlled-release formulations

Quel type d’immunité permet la production d’anticorps ? Question 30 RéponseImmunité innée interneImmunité humoraleImmunité cellulaireImmunité innée externe